TABLE OF CONTENTS
|  |  |  | Volume 33, Issue 36 (September 2014) |  | In this issue Review Original Articles Short Communication
Also new    AOP | |  |  |  | | Advertisement |  | Our Impact Factor has increased!
Oncogene celebrates a new, higher Impact Factor of 8.559*. Thank you for your support!
Subscribe to Oncogene and you'll never have to miss the latest developments in cancer research.
*2013 Journal Citation Reports® (Thomson Reuters, 2014) | | | |  |  | Review | Top |  | Targeting cancer stem cells to suppress acquired chemotherapy resistanceS J Vidal, V Rodriguez-Bravo, M Galsky, C Cordon-Cardo and J Domingo-Domenech Oncogene 2014 33: 4451-4463; advance online publication, October 7, 2013; 10.1038/onc.2013.411 Abstract | Full Text |  | Original Articles | Top |  | EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer riskI M Wilson, E A Vucic, K S S Enfield, K L Thu, Y A Zhang, R Chari, W W Lockwood, N Radulovich, D T Starczynowski, J P Banáth, M Zhang, A Pusic, M Fuller, K M Lonergan, D Rowbotham, J Yee, J C English, T P H Buys, S A Selamat, I A Laird-Offringa, P Liu, M Anderson, M You, M S Tsao, C J Brown, K L Bennewith, C E MacAulay, A Karsan, A F Gazdar, S Lam and W L Lam Oncogene 2014 33: 4464-4473; advance online publication, October 7, 2013; 10.1038/onc.2013.396 Abstract | Full Text |  |  |  | Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progressionF Bengsch, A Buck, S C Günther, J R Seiz, M Tacke, D Pfeifer, D von Elverfeldt, L Sevenich, L E Hillebrand, U Kern, M Sameni, C Peters, B F Sloane and T Reinheckel Oncogene 2014 33: 4474-4484; advance online publication, September 30, 2013; 10.1038/onc.2013.395 Abstract | Full Text |  |  |  | Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastasesJ Ueda, Y Matsuda, K Yamahatsu, E Uchida, Z Naito, M Korc and T Ishiwata Oncogene 2014 33: 4485-4495; advance online publication, September 30, 2013; 10.1038/onc.2013.392 Abstract | Full Text |  |  |  | MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis OPENS-H Chan, W-C Huang, J-W Chang, K-J Chang, W-H Kuo, M-Y Wang, K-Y Lin, Y-H Uen, M-F Hou, C-M Lin, T-H Jang, C-W Tu, Y-R Lee, Y-H Lee, M-T Tien and L-H Wang Oncogene 2014 33: 4496-4507; advance online publication, March 10, 2014; 10.1038/onc.2014.10 Abstract | Full Text |  |  |  | c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancerL S Fiore, S S Ganguly, J Sledziona, M L Cibull, C Wang, D L Richards, J M Neltner, C Beach, J R McCorkle, D M Kaetzel and R Plattner Oncogene 2014 33: 4508-4520; advance online publication, October 7, 2013; 10.1038/onc.2013.399 Abstract | Full Text |  |  |  | Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model OPENH G Nguyen, J C Yang, H-J Kung, X-B Shi, D Tilki, P N Lara, Jr, R W DeVere White, A C Gao and C P Evans Oncogene 2014 33: 4521-4530; advance online publication, March 24, 2014; 10.1038/onc.2014.25 Abstract | Full Text |  | Short Communication | Top |  | Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signalingR Kamekura, K N Kolegraff, P Nava, R S Hilgarth, M Feng, C A Parkos and A Nusrat Oncogene 2014 33: 4531-4536; advance online publication, October 28, 2013; 10.1038/onc.2013.442 Abstract | Full Text |  |  |  |  | | Advertisement |  | | Scientific Data will be attending the American Society of Human Genetics conference on 19th - 21st October. Come and visit us at the Nature booth #1321-1323 to learn more. | | | |  |  |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  | |  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment